Información de la revista
Review
Acceso a texto completo
Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies
Perfil de efectividad y seguridad de tenapanor, un inhibidor de la isoforma 3 del intercambiador de sodio/hidrógeno, como tratamiento innovador para la hiperfosfatemia en la enfermedad renal crónica, una revisión sistemática de estudios clínicos
William Suciangtoa,
, Haerani Rasyidb, Anastasya Angelica Vicentec, Winny Suciangtoa
a Department of Medical Doctor Study Program, Faculty of Medicine, Hasanuddin University, Makassar City, South Sulawesi Province, Indonesia
b Division of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Makassar City, South Sulawesi Province, Indonesia
c Department of Physiology, Faculty of Medicine, Hasanuddin University, Makassar City, South Sulawesi Province, Indonesia

Artículo

This article is available in English

Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies

William Suciangto, Haerani Rasyid, Anastasya Angelica Vicente, Winny Suciangto
10.1016/j.nefroe.2024.11.015
Nefrologia (English Version). 2024;44:796-806
Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?